| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of DNA vaccines for the rabies-related virus, Mokola
|
Nel, L.H
|
|
2003
|
21 |
19-20 |
p. 2598-2606
9 p.
|
article
|
| 2 |
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
|
Clarke, S.C.
|
|
2003
|
21 |
19-20 |
p. 2468-2473
6 p.
|
article
|
| 3 |
Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms
|
Burns, Victoria E
|
|
2003
|
21 |
19-20 |
p. 2523-2534
12 p.
|
article
|
| 4 |
Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response
|
Syed, Faisal M.
|
|
2003
|
21 |
19-20 |
p. 2383-2393
11 p.
|
article
|
| 5 |
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant
|
Halperin, Scott A
|
|
2003
|
21 |
19-20 |
p. 2461-2467
7 p.
|
article
|
| 6 |
A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)
|
Huang, Yan
|
|
2003
|
21 |
19-20 |
p. 2500-2505
6 p.
|
article
|
| 7 |
Biodefense Vaccines, Therapeutics and Diagnostics: Policy, Funding, Development, Testing, Production, and Distribution Conference, June 2–4, 2003, Washington, DC
|
|
|
2003
|
21 |
19-20 |
p. 2690-
1 p.
|
article
|
| 8 |
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation
|
Brandão, Joana G.
|
|
2003
|
21 |
19-20 |
p. 2268-2272
5 p.
|
article
|
| 9 |
Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming
|
Wang, Xiuqing
|
|
2003
|
21 |
19-20 |
p. 2288-2297
10 p.
|
article
|
| 10 |
Comments on the paper “The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data” [P. Rivest, R. Allard, Vaccine 20 (2002) 2533–2536]
|
De Wals, Philippe
|
|
2003
|
21 |
19-20 |
p. 2260-2261
2 p.
|
article
|
| 11 |
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice
|
Pihlgren, Maria
|
|
2003
|
21 |
19-20 |
p. 2492-2499
8 p.
|
article
|
| 12 |
Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned
|
Capiau, Carine
|
|
2003
|
21 |
19-20 |
p. 2273-2287
15 p.
|
article
|
| 13 |
Editorial Board
|
|
|
2003
|
21 |
19-20 |
p. IFC-
1 p.
|
article
|
| 14 |
Effect of infant immunisation with meningococcus serogroup C–CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children
|
McVernon, Jodie
|
|
2003
|
21 |
19-20 |
p. 2573-2579
7 p.
|
article
|
| 15 |
Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct
|
Nicholas, B.L.
|
|
2003
|
21 |
19-20 |
p. 2441-2447
7 p.
|
article
|
| 16 |
Effect of Vitamin A supplementation on the immune response to measles vaccination
|
Cherian, Thomas
|
|
2003
|
21 |
19-20 |
p. 2418-2420
3 p.
|
article
|
| 17 |
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
|
Plotnicky, Hélène
|
|
2003
|
21 |
19-20 |
p. 2651-2660
10 p.
|
article
|
| 18 |
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation
|
Kotecha, Minal T.
|
|
2003
|
21 |
19-20 |
p. 2506-2515
10 p.
|
article
|
| 19 |
Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280]
|
Edelman, Robert
|
|
2003
|
21 |
19-20 |
p. 2689-
1 p.
|
article
|
| 20 |
Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: identification of shared and vaccine-specific genes in spleen lymphocytes
|
Regnström, Karin
|
|
2003
|
21 |
19-20 |
p. 2307-2317
11 p.
|
article
|
| 21 |
Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids
|
Rollman, E.
|
|
2003
|
21 |
19-20 |
p. 2263-2267
5 p.
|
article
|
| 22 |
HAV infection in chronic liver disease: a rationale for vaccination
|
Almasio, Piero L.
|
|
2003
|
21 |
19-20 |
p. 2238-2241
4 p.
|
article
|
| 23 |
Hepatitis A: post-exposure prophylaxis
|
Taliani, Gloria
|
|
2003
|
21 |
19-20 |
p. 2234-2237
4 p.
|
article
|
| 24 |
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
|
Yeh, Sylvia H
|
|
2003
|
21 |
19-20 |
p. 2627-2631
5 p.
|
article
|
| 25 |
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite–threonine–asparagine-rich protein (STARP)
|
López, Ramsés
|
|
2003
|
21 |
19-20 |
p. 2404-2411
8 p.
|
article
|
| 26 |
IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis
|
de Oliveira Mendes, Carolina
|
|
2003
|
21 |
19-20 |
p. 2589-2597
9 p.
|
article
|
| 27 |
Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1
|
Martina, Byron E.E
|
|
2003
|
21 |
19-20 |
p. 2433-2440
8 p.
|
article
|
| 28 |
Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys
|
Tanabayashi, Kiyoshi
|
|
2003
|
21 |
19-20 |
p. 2338-2345
8 p.
|
article
|
| 29 |
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis
|
Piedra, Pedro A.
|
|
2003
|
21 |
19-20 |
p. 2448-2460
13 p.
|
article
|
| 30 |
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2
|
Mozdzanowska, Krystyna
|
|
2003
|
21 |
19-20 |
p. 2616-2626
11 p.
|
article
|
| 31 |
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2)
|
Nguyen, Christophe L.
|
|
2003
|
21 |
19-20 |
p. 2318-2328
11 p.
|
article
|
| 32 |
Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity
|
Fowler, Sarah
|
|
2003
|
21 |
19-20 |
p. 2329-2337
9 p.
|
article
|
| 33 |
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity
|
Shanley, John D.
|
|
2003
|
21 |
19-20 |
p. 2632-2642
11 p.
|
article
|
| 34 |
Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6
|
de Lorimier, Arthur J
|
|
2003
|
21 |
19-20 |
p. 2548-2555
8 p.
|
article
|
| 35 |
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine
|
Halperin, Scott A.
|
|
2003
|
21 |
19-20 |
p. 2298-2306
9 p.
|
article
|
| 36 |
Novel configurations of high molecular weight species of the pertussis toxin vaccine component
|
Fowler, Sarah
|
|
2003
|
21 |
19-20 |
p. 2678-2688
11 p.
|
article
|
| 37 |
Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine
|
De Serres, Gaston
|
|
2003
|
21 |
19-20 |
p. 2346-2353
8 p.
|
article
|
| 38 |
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei
|
Meraldi, Valentin
|
|
2003
|
21 |
19-20 |
p. 2485-2491
7 p.
|
article
|
| 39 |
Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex
|
Shkreta, Lulzim
|
|
2003
|
21 |
19-20 |
p. 2372-2382
11 p.
|
article
|
| 40 |
Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice
|
Scappaticci, F.A.
|
|
2003
|
21 |
19-20 |
p. 2667-2677
11 p.
|
article
|
| 41 |
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
|
Purcell, Robert H
|
|
2003
|
21 |
19-20 |
p. 2607-2615
9 p.
|
article
|
| 42 |
Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK.
|
Ramiro, Maria J.
|
|
2003
|
21 |
19-20 |
p. 2474-2484
11 p.
|
article
|
| 43 |
Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach
|
Senna, José P.M
|
|
2003
|
21 |
19-20 |
p. 2661-2666
6 p.
|
article
|
| 44 |
Reconstruction of measles dynamics in a vaccinated population
|
Wallinga, J.
|
|
2003
|
21 |
19-20 |
p. 2643-2650
8 p.
|
article
|
| 45 |
Reply to the letter of Drs De Wals and De Serres
|
Allard, Robert
|
|
2003
|
21 |
19-20 |
p. 2262-
1 p.
|
article
|
| 46 |
Risk groups for hepatitis A virus infection
|
Franco, Elisabetta
|
|
2003
|
21 |
19-20 |
p. 2224-2233
10 p.
|
article
|
| 47 |
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia
|
Ito, Reiko
|
|
2003
|
21 |
19-20 |
p. 2362-2371
10 p.
|
article
|
| 48 |
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age
|
Qadri, Firdausi
|
|
2003
|
21 |
19-20 |
p. 2394-2403
10 p.
|
article
|
| 49 |
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs
|
Verheije, M.H.
|
|
2003
|
21 |
19-20 |
p. 2556-2563
8 p.
|
article
|
| 50 |
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)
|
Van der Wielen, Marie
|
|
2003
|
21 |
19-20 |
p. 2412-2417
6 p.
|
article
|
| 51 |
Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS
|
Fincham, John E.
|
|
2003
|
21 |
19-20 |
p. 2258-2259
2 p.
|
article
|
| 52 |
The association between psychosocial factors and vaccine-induced cytokine production
|
Hayney, Mary S.
|
|
2003
|
21 |
19-20 |
p. 2428-2432
5 p.
|
article
|
| 53 |
The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination
|
De Serres, Gaston
|
|
2003
|
21 |
19-20 |
p. 2354-2361
8 p.
|
article
|
| 54 |
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine
|
McIntosh, E.David G.
|
|
2003
|
21 |
19-20 |
p. 2564-2572
9 p.
|
article
|
| 55 |
The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity
|
Wu, Suh-Chin
|
|
2003
|
21 |
19-20 |
p. 2516-2522
7 p.
|
article
|
| 56 |
The effectiveness and safety of hepatitis A vaccine: a systematic review
|
Demicheli, Vittorio
|
|
2003
|
21 |
19-20 |
p. 2242-2245
4 p.
|
article
|
| 57 |
The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children
|
Rager-Zisman, Bracha
|
|
2003
|
21 |
19-20 |
p. 2580-2588
9 p.
|
article
|
| 58 |
The incidence of shingles and its implications for vaccination policy
|
Chapman, Rachel S.
|
|
2003
|
21 |
19-20 |
p. 2541-2547
7 p.
|
article
|
| 59 |
The role of vaccine in controlling hepatitis A epidemics
|
D’Argenio, P
|
|
2003
|
21 |
19-20 |
p. 2246-2249
4 p.
|
article
|
| 60 |
The use of hepatitis a vaccination in Italy: an economic evaluation
|
Demicheli, Vittorio
|
|
2003
|
21 |
19-20 |
p. 2250-2257
8 p.
|
article
|
| 61 |
The use of hepatitis A vaccine in Italy—evidence-based recommendations from an expert panel
|
Mele, Alfonso
|
|
2003
|
21 |
19-20 |
p. 2223-
1 p.
|
article
|
| 62 |
Three types of immunotherapics against pythiosis insidiosi developed and evaluated
|
Santurio, J.M
|
|
2003
|
21 |
19-20 |
p. 2535-2540
6 p.
|
article
|
| 63 |
Why do older people not get immunised against influenza?
|
Evans, Meirion R.
|
|
2003
|
21 |
19-20 |
p. 2421-2427
7 p.
|
article
|
Journal description